Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer

NCT00629057 is registered in ClinicalTrials.gov with Bavarian Nordic as lead sponsor.

NCT NCT00629057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00629057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Lead sponsor
Bavarian Nordic
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2008
Completion date
September 30, 2011
Enrollment
24 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

androgen-insensitive prostate cancer